Literature DB >> 15979165

Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins.

Bazbek Davletov1, Mark Bajohrs, Thomas Binz.   

Abstract

Botulinum neurotoxins are the most potent toxins designed by nature. They are produced by Clostridium bacteria to cause long-lasting paralysis and death. However, in the past century one member of the botulinum family--botulinum neurotoxin type A--has been put to good use, and is now widely employed in clinical neurology and, even more often, in beauty clinics. This article will critically assess the value of individual members of the botulinum family for experimental neuroscience and medicine. The seven botulinum neurotoxins all act by targeting the same vesicle fusion machinery, and yet they cause paralysis of different durations. The distinct behaviors of botulinum neurotoxins will be discussed, with the aim of highlighting advantages and limitations for their future exploitation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979165     DOI: 10.1016/j.tins.2005.06.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  45 in total

1.  Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.

Authors:  Frédéric Darios; Dhevahi Niranjan; Enrico Ferrari; Fan Zhang; Mikhail Soloviev; Andreas Rummel; Hans Bigalke; Jason Suckling; Yuri Ushkaryov; Nikolay Naumenko; Anastasia Shakirzyanova; Rashid Giniatullin; Elizabeth Maywood; Michael Hastings; Thomas Binz; Bazbek Davletov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

3.  Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin.

Authors:  Tori Matthys; Hong An Ho Dang; Katherine L Rafferty; Susan W Herring
Journal:  Am J Orthod Dentofacial Orthop       Date:  2015-12       Impact factor: 2.650

4.  Bimodal modulation of the botulinum neurotoxin protein-conducting channel.

Authors:  Audrey Fischer; Yuya Nakai; Lisa M Eubanks; Colin M Clancy; William H Tepp; Sabine Pellett; Tobin J Dickerson; Eric A Johnson; Kim D Janda; Mauricio Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 5.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

6.  Unique substrate recognition mechanism of the botulinum neurotoxin D light chain.

Authors:  Jiubiao Guo; Sheng Chen
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

7.  Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.

Authors:  Abby R Kroken; Faith C Blum; Madison Zuverink; Joseph T Barbieri
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

8.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

9.  Loss of granuphilin and loss of syntaxin-1A cause differential effects on insulin granule docking and fusion.

Authors:  Hao Wang; Ray Ishizaki; Eri Kobayashi; Tomonori Fujiwara; Kimio Akagawa; Tetsuro Izumi
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

10.  Enhancing the protective immune response against botulism.

Authors:  Amanda Przedpelski; William H Tepp; Abby R Kroken; Zhuji Fu; Jung-Ja P Kim; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.